Zacks: Brokerages Anticipate Itron, Inc. (NASDAQ:ITRI) Will Post Quarterly Sales of $597.10 Million
Analysts expect Itron, Inc. (NASDAQ:ITRI) to post $597.10 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Itron’s earnings, with estimates ranging from $585.20 million to $609.00 million. Itron reported sales of $587.04 million in the same quarter last year, which would suggest a positive year over year growth rate of 1.7%. The company is scheduled to announce its next earnings report after the market closes on Monday, February 24th.
On average, analysts expect that Itron will report full-year sales of $2.47 billion for the current year, with estimates ranging from $2.46 billion to $2.48 billion. For the next financial year, analysts anticipate that the business will post sales of $2.52 billion, with estimates ranging from $2.48 billion to $2.57 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Itron.
Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Monday, November 4th. The scientific and technical instruments company reported $1.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.38. Itron had a return on equity of 18.69% and a net margin of 2.37%. The firm had revenue of $624.47 million for the quarter, compared to analysts’ expectations of $622.63 million. During the same period in the prior year, the business posted $1.13 earnings per share. The company’s revenue was up 4.8% on a year-over-year basis.
A number of institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC raised its position in shares of Itron by 76.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the scientific and technical instruments company’s stock valued at $31,000 after buying an additional 160 shares in the last quarter. NumerixS Investment Technologies Inc increased its stake in Itron by 50.0% in the second quarter. NumerixS Investment Technologies Inc now owns 600 shares of the scientific and technical instruments company’s stock valued at $38,000 after acquiring an additional 200 shares during the last quarter. Trillium Asset Management LLC increased its stake in Itron by 0.6% in the third quarter. Trillium Asset Management LLC now owns 67,019 shares of the scientific and technical instruments company’s stock valued at $4,957,000 after acquiring an additional 380 shares during the last quarter. Strs Ohio increased its stake in Itron by 18.2% in the fourth quarter. Strs Ohio now owns 2,600 shares of the scientific and technical instruments company’s stock valued at $218,000 after acquiring an additional 400 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Itron during the fourth quarter valued at about $39,000. Institutional investors and hedge funds own 95.53% of the company’s stock.
NASDAQ:ITRI traded down $1.13 during mid-day trading on Friday, hitting $86.27. 205,696 shares of the stock traded hands, compared to its average volume of 188,442. The business’s 50-day moving average price is $84.55 and its 200 day moving average price is $74.85. The company has a market cap of $3.46 billion, a PE ratio of 59.09, a price-to-earnings-growth ratio of 0.97 and a beta of 1.10. Itron has a 12-month low of $45.54 and a 12-month high of $88.22. The company has a quick ratio of 1.07, a current ratio of 1.41 and a debt-to-equity ratio of 1.31.
Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
Read More: What does a neutral rating on stocks mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.